Ilseong Doxium Tablet (Dovecyl Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500-1000mg daily 2. Venous disease: Administer 750mg daily for 1-3 weeks, then administer 500mg daily. Take after meals with plenty of fluids. Adjust the dose appropriately according to age and symptoms.

This medication should not be used by individuals who are allergic to this medication or its components. This medication contains lactose, so it should not be taken by individuals with a genetic disorder that prevents lactose digestion. Patients with poor kidney function should use this medication with caution, and particularly patients with severe kidney disease requiring dialysis may need to reduce the dosage. Patients with liver dysfunction should also be cautious when using this medication, and if liver enzyme levels rise, the effectiveness and risks of treatment should be re-evaluated. This medication contains sulfites, which may cause severe allergic reactions in individuals allergic to sulfites or those with asthma. Occasionally, agranulocytosis may develop during treatment, leading to a sudden decrease in blood cell count; if symptoms of high fever or infection appear, contact a doctor immediately. Additionally, if hypersensitivity reactions such as skin rashes, itching, hives, or facial swelling occur, discontinue use. Common symptoms may include headache, abdominal pain, nausea, diarrhea, vomiting, joint pain, and muscle pain, but typically resolve upon discontinuation of treatment. The effects on driving or operating machinery are not known, so caution is needed. It is advisable to avoid this medication during pregnancy, and during breastfeeding, it is preferable to either discontinue the medication or stop breastfeeding. The safety in children has not been sufficiently studied, so caution is required in their use. There are no special precautions for the elderly, but dosage should be considered based on general health conditions. This medication may affect some blood test results, so it is recommended to collect test samples prior to administration. No specific symptoms have been reported in case of overdose, but if an overdose is suspected, immediate emergency treatment should be sought.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• urticaria
• facial edema
• anaphylactic reaction
• headache

This medication should be stored in a sealed container to prevent air or moisture from entering. Proper storage will help maintain the effectiveness of the medication for a long time.

Appearance

White round tablets

Package unit

90 tablets/bottle, 30 tablets/bottle